Conclusion Of A Non-Exclusive Discount Agreement In Accordance With § 130A Paragraph 8 Sgb V For The Active Substance Duloxetine (Only Strengths 90 Mg And 120 Mg), Atc N06Ax21 For The Period 06/01/2023 - 05/31/2025

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 65122566

  Document Type - Tender Notices

Description - § 130a paragraph 8 SGB V enables the health insurance companies and pharmaceutical companies to conclude framework discount agreements for the drugs to be supplied at the expense of the statutory health insurance companies. With regard to the releva nt legal regulations for the award of public contracts, a regular process of active substance-related, formal award procedures takes place according to the regulations of the 4th part of the GWB by the DAK-Gesundheit. For pharmaceuticals to be specified by the bidder in Annex 2 to the contract for the above-mentioned active ingredient duloxetine (exclusively strengths 90 mg and 120 mg), ATC N06AX21, DAK-Gesundheit intends to conclude drug discoun

Gt Ref Id - 65122566

Deadline - Apr 05, 2025